Press Releases

Dr. Susan Hardin, President and CEO of VisiGen Biotechnologies Inc. short-listed for 2006 World Technology Award

New York October 6, 2006 - The World Technology Network (WTN) announced today that Dr. Susan Hardin, from VisiGen Biotechnologies Inc., has been short-listed as a nominee for a 2006 World Technology Award, presented by the World Technology Network, in association with the New York Stock Exchange (NYSE), Dow Chemical, TIME magazine and CNN, among others Susan Hardin is eligible to be selected as the Winner of the 2006 World Technology Award for Health and Medicine.  

Winners will be announced on November 3rd, 2006, in San Francisco, at the World Technology Awards gala ceremony at San Francisco City Hall at the conclusion of the two-day World Technology Summit.  The World Technology Awards honor individuals and corporations from twenty (20) technology-related sectors viewed by their peers as being the most innovative and doing the work of the greatest likely long-term significance.  Award categories range from biotechnology, space and energy through to ethics, design and entertainment.

Susan Hardin commented: “I am honored to be identified by my peers as a finalist for the World Technology Award for Health and Medicine.”

Nominees for the 2006 World Technology Awards were identified based on an intensive, global process over a period of many months in which current individual WTN members (primarily elected WTN Fellows from previous Awards cycles), who now number over 800, spread out over 60 countries) made their nominations based on who they think is doing the innovative work in their field of the greatest likely long-term significance. After the WTN gathers further information from and about nominees, WTN individual members then vote on their preferences within their category. The top five selections (sometimes a few more, in the case of ties) are then inducted into our WTN membership base as Fellows, with one of them announced as the Winner of their Award category at the Awards ceremony.

A small selection of those WTN members in the 20 different award categories who nominated/judged/voted in the past two years can be found at this website:  http://www.wtn.net/members/individual.html

James P. Clark, founder and Chairman of the World Technology Network, added: 
“The World Technology Awards program is not only a very inspiring way to identify and honor the most innovative people and organizations in the technology world, but it also is a truly disciplined way for the WTN membership to identify those who will formally join them, as WTN Fellows, as part of our global community. By working to make useful connections among our members, we look forward to assisting Dr. Hardin continue to help create our collective future and change our world."

This year’s World Technology Awards ceremony will cap the 2006 World Technology Summit taking place in San Francisco on the 2nd and 3rd of November, at the historic Fairmont Hotel. The Summit will also include a Chief Technology Officer (CTO) Showcase, enabling a small selection of companies to discuss and “demo” their work in detail with Summit delegates. For more information on the World Technology Network, World Technology Awards and World Technology Summit, please visit this website: www.wtn.net

About World Technology Network

The World Technology Network is a New York-headquartered organization that was created to "encourage serendipity"  - happy accidents - amongst those individuals and companies deemed by their peers to be the most innovative in the science and technology world.  The WTN's areas of interest range from IT and communications to biotech, energy, materials, space, as well as related fields such as finance, marketing, policy, law, design, and ethics.  Each year, WTN members are brought together through an ongoing global series of regional roundtables, global Summits, and other events. The WTN also convened the World Energy Technologies Summit at UNESCO headquarters in Paris. The WTN also publishes "The WTN Update”, a monthly collection of news items covering the innovative work of the WTN members. The central events in the WTN calendar include the annual World Technology Summit and World Technology Awards - the culmination of a global judging program through which new members are nominated and selected and by which the network grows and is refreshed.

About Dr. Susan Hardin

Dr. Susan Hardin received an undergraduate degree in Biology at Penn State University in 1982, and a Ph.D. in Molecular, Cellular, and Developmental Biology from Indiana University in 1987. She performed postdoctoral work at Brandeis University in Waltham Massachusetts. Dr. Hardin became the Director of the Gene Technologies Laboratory at Texas A&M University in 1991, joined the faculty at the University of Houston as an Assistant Professor of Biology and Biochemistry in 1995, and was promoted to Associate Professor in 2002. In August 2005, she resigned her tenured professorship, but retains Adjunct Professor status.

Dr. Hardin is an active member of the Association of Biomolecular Research Facilities and was elected to the ABRF Executive Board. She is a 2004 American Women in Computing, Houston, Top Women in Technology Honoree, and was recently inducted to the American Institute of Medical and Biological Engineering 2006 College of Fellows. In 2006 she will also receive a Penn State Eberly College of Science Outstanding Science Alumni Award. "The Outstanding Science alumni Awards are presented annually to recognize and reward outstanding Penn State alumni for their success as leaders in science and for the impact they have had and will continue to have on society and their professions." 

Dr. Hardin's research interests are in the areas of molecular genetics and biotechnology, especially with respect to the mechanisms of enzymatic DNA synthesis and DNA replication. She has published papers on novel methods for sequencing DNA, has issued patents, and several patents pending.

About VisiGen

VisiGen LogoVisiGen, a privately-held company based in Houston, TX, is developing a radically new method of sequencing DNA that is projected to completely sequence a human genome in a day for the long-coveted target mark of $1000. Its technology is distinguished from other next generation sequencing technologies in that it exploits the natural process of DNA replication in a way that enhances accuracy without drastically impacting efficiency. VisiGen’s approach involves engineering both polymerase and nucleotide triphosphates to act together as direct molecular sensors of DNA base identity in real-time. The massively parallel nature of this technology enables sequence acquisition at rates approaching 1 million bases per second per machine.

Contact Information

Susan Hardin
President and CEO
VisiGen Biotechnologies, Inc.
shardin@visigenbio.com

James P. Clark

Founder and Chairman

World Technology Network

jpclark@wtn.net

415 839 6358